Generic drug sales drive Abbott revenue
October 21, 2015 at 07:52 AM EDT
Oct 21 (Reuters) - Drugmaker Abbott Laboratories Inc reported a 2 percent rise in sales, helped by higher demand for its generic drugs in emerging markets.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.